CVM
Price
$2.40
Change
-$0.04 (-1.64%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
12.32M
MNOV
Price
$1.33
Change
+$0.03 (+2.31%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
65.23M
41 days until earnings call
QNRX
Price
$9.40
Change
-$0.33 (-3.39%)
Updated
Jun 27, 03:34 PM (EDT)
Capitalization
5.45M
Interact to see
Advertisement

CVM or MNOV or QNRX

Header iconCVM vs MNOV vs QNRX Comparison
Open Charts CVM vs MNOV vs QNRXBanner chart's image
Cel-Sci
Price$2.40
Change-$0.04 (-1.64%)
Volume$600
Capitalization12.32M
Medicinova
Price$1.33
Change+$0.03 (+2.31%)
Volume$1.36K
Capitalization65.23M
Quoin Pharmaceuticals
Price$9.40
Change-$0.33 (-3.39%)
Volume$100
Capitalization5.45M
CVM vs MNOV vs QNRX Comparison Chart in %
Loading...
CVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MNOV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (CVM: $2.40MNOV: $1.33QNRX: $9.27)
Brand notoriety: MNOV and QNRX are not notable and CVM is notable
The three companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CVM: 25%, MNOV: 61%, QNRX: 1%
Market capitalization -- CVM: $12.32M, MNOV: $65.23M, QNRX: $5.45M
$CVM is valued at $12.32M, while MNOV has a market capitalization of $65.23M, and QNRX's market capitalization is $5.45M. The market cap for tickers in this @Biotechnology ranges from $299.85B to $0. The average market capitalization across the @Biotechnology industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CVM’s FA Score shows that 0 FA rating(s) are green whileMNOV’s FA Score has 0 green FA rating(s), and QNRX’s FA Score reflects 2 green FA rating(s).

  • CVM’s FA Score: 0 green, 5 red.
  • MNOV’s FA Score: 0 green, 5 red.
  • QNRX’s FA Score: 2 green, 3 red.
According to our system of comparison, QNRX is a better buy in the long-term than MNOV, which in turn is a better option than CVM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CVM’s TA Score shows that 3 TA indicator(s) are bullish while MNOV’s TA Score has 4 bullish TA indicator(s), and QNRX’s TA Score reflects 5 bullish TA indicator(s).

  • CVM’s TA Score: 3 bullish, 4 bearish.
  • MNOV’s TA Score: 4 bullish, 5 bearish.
  • QNRX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, QNRX is a better buy in the short-term than CVM and MNOV.

Price Growth

CVM (@Biotechnology) experienced а +4.80% price change this week, while MNOV (@Biotechnology) price change was +3.10% , and QNRX (@Biotechnology) price fluctuated +6.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

CVM is expected to report earnings on May 15, 2025.

MNOV is expected to report earnings on Aug 08, 2025.

QNRX is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MNOV($65.2M) has a higher market cap than CVM($12.3M) and QNRX($5.45M). MNOV YTD gains are higher at: -36.667 vs. QNRX (-59.297) and CVM (-79.995). QNRX has higher annual earnings (EBITDA): -10.93M vs. MNOV (-12.72M) and CVM (-21.96M). MNOV has more cash in the bank: 36.6M vs. QNRX (11.6M) and CVM (1.92M). MNOV has less debt than QNRX and CVM: MNOV (190K) vs QNRX (6.21M) and CVM (10.5M). CVM (0), MNOV (0) and QNRX (0) have equivalent revenues.
CVMMNOVQNRX
Capitalization12.3M65.2M5.45M
EBITDA-21.96M-12.72M-10.93M
Gain YTD-79.995-36.667-59.297
P/E RatioN/AN/AN/A
Revenue000
Total Cash1.92M36.6M11.6M
Total Debt10.5M190K6.21M
FUNDAMENTALS RATINGS
CVM vs MNOV vs QNRX: Fundamental Ratings
CVM
MNOV
QNRX
OUTLOOK RATING
1..100
56115
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
43
Fair valued
20
Undervalued
PROFIT vs RISK RATING
1..100
100100100
SMR RATING
1..100
1009499
PRICE GROWTH RATING
1..100
968264
P/E GROWTH RATING
1..100
541001
SEASONALITY SCORE
1..100
n/a21n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QNRX's Valuation (20) in the Biotechnology industry is in the same range as MNOV (43) and is significantly better than the same rating for CVM (98). This means that QNRX's stock grew similarly to MNOV’s and significantly faster than CVM’s over the last 12 months.

QNRX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as MNOV (100) and is in the same range as CVM (100). This means that QNRX's stock grew similarly to MNOV’s and similarly to CVM’s over the last 12 months.

MNOV's SMR Rating (94) in the Biotechnology industry is in the same range as QNRX (99) and is in the same range as CVM (100). This means that MNOV's stock grew similarly to QNRX’s and similarly to CVM’s over the last 12 months.

QNRX's Price Growth Rating (64) in the Biotechnology industry is in the same range as MNOV (82) and is in the same range as CVM (96). This means that QNRX's stock grew similarly to MNOV’s and similarly to CVM’s over the last 12 months.

QNRX's P/E Growth Rating (1) in the Biotechnology industry is somewhat better than the same rating for CVM (54) and is significantly better than the same rating for MNOV (100). This means that QNRX's stock grew somewhat faster than CVM’s and significantly faster than MNOV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CVMMNOVQNRX
RSI
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 19 days ago
81%
Bullish Trend 5 days ago
71%
Bullish Trend 3 days ago
87%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 2 days ago
85%
Bearish Trend 15 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MNOV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XBP0.940.01
+1.49%
XBP Europe Holdings
GE254.513.51
+1.40%
GE Aerospace
TRMK36.780.35
+0.96%
Trustmark Corp
KODK5.75-0.02
-0.35%
Eastman Kodak Company
GMED58.60-0.22
-0.37%
Globus Medical

CVM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CVM has been loosely correlated with NRXS. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if CVM jumps, then NRXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVM
1D Price
Change %
CVM100%
-1.64%
NRXS - CVM
58%
Loosely correlated
-1.59%
MDGL - CVM
43%
Loosely correlated
+0.45%
CYTK - CVM
40%
Loosely correlated
-2.21%
ADXN - CVM
39%
Loosely correlated
+2.18%
EYPT - CVM
38%
Loosely correlated
-6.94%
More

MNOV and

Correlation & Price change

A.I.dvisor indicates that over the last year, MNOV has been loosely correlated with FATE. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if MNOV jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNOV
1D Price
Change %
MNOV100%
+2.31%
FATE - MNOV
36%
Loosely correlated
-5.45%
MNKD - MNOV
30%
Poorly correlated
-0.40%
VIR - MNOV
29%
Poorly correlated
-2.73%
TIL - MNOV
28%
Poorly correlated
+3.61%
QLGN - MNOV
28%
Poorly correlated
+0.28%
More

QNRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, QNRX has been loosely correlated with ATNF. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if QNRX jumps, then ATNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNRX
1D Price
Change %
QNRX100%
-4.73%
ATNF - QNRX
35%
Loosely correlated
-4.27%
ATNM - QNRX
35%
Loosely correlated
-12.35%
WVE - QNRX
32%
Poorly correlated
-5.12%
PRQR - QNRX
30%
Poorly correlated
-5.56%
ALGS - QNRX
29%
Poorly correlated
+0.98%
More